Who owns the LYVANTA trademark?

The LYVANTA trademark is owned by U-Ploid Biotechnologies Ltd.

What class is the LYVANTA trademark registered in?

The LYVANTA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LYVANTA?

The USPTO serial number for LYVANTA is 79439722.

What is the registration number for LYVANTA?

LYVANTA is registered under USPTO registration number 0.

Sealvo

Home Search: LYVANTALYVANTA #79439722

Back

Updated Oct 6, 2026·16 searches this week

View on USPTO TSDR Find similar marks

LYV

USPTO Trademark Record

PENDING

LYVANTA

SN 79439722·Reg 0·Filed Nov 11, 2025

Owner U-Ploid Biotechnologies Ltd

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LYVANTA (Serial No. 79439722), Registration No. 0, is a pending US trademark filed on Nov 11, 2025 by U-Ploid Biotechnologies Ltd. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

LYVANTA (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 2 opposition proceedings during prosecution.

FILED

Nov 11, 2025

SERIAL

79439722

REG#

Filing Information

StatusPENDING

Filing DateNov 11, 2025

Serial Number79439722

Registration No.0

Status DateSep 14, 2026

Published for OppositionOct 06, 2026

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 30, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Sep 16, 2026

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 16, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 04, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 26, 2026

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 26, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 26, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

FINAL REFUSAL WRITTEN

Jul 27, 2026

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Jul 27, 2026

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Jul 27, 2026

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 09, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 09, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 09, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

May 21, 2026

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

May 01, 2026

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 01, 2026

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 24, 2026

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Mar 23, 2026

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Mar 20, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 29, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Dec 29, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Dec 18, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by U-Ploid Biotechnologies Ltd

Additional USPTO filings from the same owner.

UPL

U-PLOID

79439667

U-Ploid Biotechnologies Ltd

REGISTERED

Other Marks by Douglas R. Wolf

Additional USPTO filings handled by the same attorney of record.

SLE

SLEEP MANTRA

88407374

REGISTERED

BRE

BRELLIUM

99684242

REGISTERED

POW

POWERSHIFT

86629495

REGISTERED

CAS

CASCADIA

98919662

REGISTERED

LYVANTA

Run a conflict check

Other Marks by U-Ploid Biotechnologies Ltd

Other Marks by Douglas R. Wolf

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company